King Pharmaceuticals, Inc. (NYSE:KG)

CAPS Rating: No stars

The Company is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products.

Caps

How do you think KG will perform against the market?

Add Stock to CAPS Watchlist

All Players

346 Outperform
38 Underperform
 

All-Star Players

62 Outperform
11 Underperform
 

Wall Street

5 Outperform
2 Underperform
 

Top KG Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Survivn2 (23.49)
Submitted October 16, 2008

Pharma in rough times, MFI. Smaller cap than I wanted, but we'll give it a try.

aladha (62.60)
Submitted April 15, 2008

Maybe good long term once they get some direction but the market shares for their "blockbuster" products in terms of actual Rx's dispensed plus huge debt load relative to current position points to this one being flat at best until they manage to… More

KG VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about KG.

Recs

0
Member Avatar btthus (22.03) Submitted: 10/12/2010 11:10:01 AM : Outperform Start Price: $14.16 KG Score: -128.53

Price is now 14.15....
Pfizer will acquire King Pharma for $14.25 per share.

Recs

0
Member Avatar coryjobe (95.88) Submitted: 7/24/2010 3:58:39 PM : Outperform Start Price: $8.51 KG Score: -81.88

Recently had a slight setback with their drug Acurox, FDA rejected it but there is still a chance that it will get passed if the regulator says its ok. Right now they plan on submitting a new application in early 2011 with a new version of the drug that will have much better odds of getting approved. This company might not have much growth short term, but in the long term should be very profitable. They have a large number of drugs which should boost numbers in the next couple of years. Also a court ruling is causing one of the generic competitors Skelaxin off the market for now.

Recs

0
Member Avatar OpesPerPrudentia (88.66) Submitted: 4/2/2010 1:57:04 AM : Outperform Start Price: $11.96 KG Score: -106.54

Hypothyroidism based weightloss craze mixed with universal mandated healthcare = big bucks for companies that manufacture thyroid hormone drugs.

Leaderboard

Find the members with the highest scoring picks in KG.

Score Leader

nyctola

nyctola (60.25) Score: +158.28

The Score Leader is the player with the highest score across all their picks in KG.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
nyctola 60.25 1/8/2009 Underperform 3M $10.03 +41.97% +200.26% +158.28 0 Comment
tatsumaki4ryu 20.27 9/8/2006 Underperform 3Y $16.26 -12.42% +118.63% +131.06 0 Comment
NAVSKI 35.85 10/4/2006 Underperform 5Y $17.10 -16.73% +110.60% +127.33 0 Comment
EliteMerchant 98.07 10/10/2008 Underperform 5Y $7.51 +89.61% +215.48% +125.86 0 Comment
PurePwnage 99.20 11/27/2009 Underperform 5Y $11.81 +20.58% +146.11% +125.53 0 Comment
tkcha < 20 4/20/2007 Underperform 3M $20.96 -32.06% +90.28% +122.34 0 Comment
DiamondDawg 93.93 11/25/2009 Underperform 5Y $12.10 +17.69% +139.97% +122.29 0 Comment
kirket < 20 5/1/2007 Underperform 1Y $20.67 -31.11% +90.02% +121.13 0 Comment
TrackDuality < 20 11/9/2009 Underperform 5Y $11.26 +26.47% +147.13% +120.67 0 Comment
39272x4 < 20 11/9/2009 Underperform 5Y $11.26 +26.47% +147.13% +120.67 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCarisandCo 93.11 6/9/2010 Outperform NS $7.71 +84.70% +148.77% -64.07 0 Comment
TrackZacks < 20 5/5/2010 Underperform 3M $9.64 -4.77% -3.28% +1.49 8/9/2010 @ $9.18 1 Comment
TrackBMOCapital < 20 4/23/2010 Underperform NS $11.12 +28.06% +120.59% +92.53 0 Comment
TrackGoldmanSach 78.79 4/22/2010 Underperform 5Y $11.38 -23.11% -7.76% +15.35 7/26/2010 @ $8.75 1 Comment
TrackLazardCapit 78.46 10/8/2009 Outperform NS $10.36 +37.45% +150.38% -112.93 0 Comment
TrackZacks < 20 8/21/2009 Underperform 3M $10.50 +17.05% +11.30% -5.75 3/9/2010 @ $12.29 1 Comment
TrackZacks < 20 7/8/2009 Outperform 3M $9.27 +13.27% +16.86% -3.60 8/21/2009 @ $10.50 1 Comment
TrackUBS 91.96 4/20/2009 Outperform NS $8.84 +60.18% +38.22% +21.96 10/13/2010 @ $14.16 0 Comment
TrackWellsFargo 88.36 3/16/2009 Outperform NS $7.45 +91.14% +252.79% -161.65 0 Comment
TrackCowenandCo 85.95 11/14/2008 Outperform NS $9.64 +47.72% +206.08% -158.37 0 Comment
TrackJGreenblatt 66.37 4/11/2008 Outperform 1Y $8.88 -0.45% -36.51% +36.06 4/20/2009 @ $8.84 2 Comments
TrackSoros 87.19 9/30/2007 Outperform NS $11.72 +21.50% +83.19% -61.69 1 Comment
TrackCitigroup 93.05 7/17/2007 Underperform NS $19.00 -43.16% -1.39% +41.77 10/19/2007 @ $10.80 0 Comment
TrackZacks < 20 6/21/2007 Underperform 3M $20.51 -43.78% -14.34% +29.45 8/29/2008 @ $11.53 1 Comment
TrackJGreenblatt 66.37 1/1/2007 Outperform 1Y $15.92 -35.62% +3.69% -39.31 1/2/2008 @ $10.25 1 Comment
TrackBroadpointAmTech < 20 12/20/2006 Underperform NS $16.17 -15.03% +1.20% +16.23 8/10/2007 @ $13.74 0 Comment
TrackJimCramer 85.09 6/9/2006 Underperform 3W $16.50 -13.70% +127.09% +140.79 0 Comment
TrackJGreenblatt 66.37 4/13/2006 Outperform 1Y $17.65 -9.07% +10.05% -19.11 1/1/2007 @ $16.05 0 Comment

Featured Broker Partners